Story excerpt provided by Crain’s Cleveland Business.
Written by Chuck Soder.
For years, other companies have been asking Dr. Arthur “Buzz” Brown if he’d be willing to sell ChanTest.
He gave in on Oct. 29.
On that day, a much larger drug development services company, Charles River Laboratories of Wilmington, Mass., bought ChanTest for an amount that could reach $54 million.
Click here to read the complete article.
Originally published November 30, 2014.